Game-Changer in der Diagnostik von Schädelhirntraumata
Blogspan,
Wiesbaden (ots) – Testen Sie schon oder bewerten Sie noch? 19. Juli 2022 – Für die Notaufnahme ist die Glasgow Coma Scale in…
Abbott - STUDY FINDS 89% OF PATIENTS TREATED FOR PERSISTENT ATRIAL FIBRILLATION USING ABBOTT'S ABLATION DEVICE REMAIN SYMPTOM-FREE FOR AT LEAST 15 MONTHS
MarketScreener,
ABBOTT PARK, Ill. - (NYSE: ABT) announced results from the PERSIST-END study, which showed that nearly nine out of 10 patients (8…
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months
Ticker Tech,
ABBOTT PARK, Ill., April 29, 2022 /PRNewswire/ -- Abbott (NYSE: ABT) today announced results from the PERSIST-END study, which…
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months
Spoke,
Treatment with the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ resulted in patients with persistent atrial…
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months
Fox 19,
Published: Apr. 29, 2022 at 9:00 AM EDT|Updated: 22 minutes ago Treatment with the TactiCath™ Contact Force Ablation Catheter…
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months
WWSB,
Published: Apr. 29, 2022 at 9:00 AM EDT|Updated: 18 minutes ago Treatment with the TactiCath™ Contact Force Ablation Catheter…
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months
WFMZ-TV 69,
Treatment with the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ resulted in patients with persistent atrial…
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months
Wave 3 News,
Published: Apr. 29, 2022 at 9:00 AM EDT|Updated: 13 minutes ago Treatment with the TactiCath™ Contact Force Ablation Catheter…
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months
KCBD,
Published: Apr. 29, 2022 at 8:00 AM CDT|Updated: 15 minutes ago Treatment with the TactiCath™ Contact Force Ablation Catheter…
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months
Hawaii News Now,
Treatment with the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ resulted in patients with persistent atrial…
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months
KPLC 7 News,
Published: Apr. 29, 2022 at 8:00 AM CDT|Updated: 13 minutes ago Treatment with the TactiCath™ Contact Force Ablation Catheter…
News story from wrdw on Friday 29 April 2022
wrdw,
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months
WTVM,
Treatment with the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ resulted in patients with persistent atrial…
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months
NBC12,
Treatment with the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ resulted in patients with persistent atrial…
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months
WILX 10,
Treatment with the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ resulted in patients with persistent atrial…
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months
WALB,
Published: Apr. 29, 2022 at 9:00 AM EDT|Updated: 9 minutes ago Treatment with the TactiCath™ Contact Force Ablation Catheter…
Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott's Ablation Device Remain Symptom-Free for at Least 15 Months
Biospace,
Treatment with the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ resulted in patients with persistent atrial…
Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon
Bioportfolio,
Clinical Trial Data Presented at European Society of Cardiology in Munich DUBLIN and MUNICH - August 28, 2018 - Medtronic plc (NY…
Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon
Benzinga,
Clinical Trial Data Presented at European Society of Cardiology in Munich DUBLIN and MUNICH - August 28, 2018 - Medtronic plc (NY…
Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon
Ariva,
Clinical Trial Data Presented at European Society of Cardiology in Munich DUBLIN and MUNICH - August 28, 2018 - Medtronic plc (NY…
Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon
Press of Atlantic City ,
Clinical Trial Data Presented at European Society of Cardiology in Munich DUBLIN and MUNICH - August 28, 2018 - Medtronic plc (NY…
News story from Finanz Nachrichten on Tuesday 28 August 2018
Finanz Nachrichten,
Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon
NASDAQ,
Clinical Trial Data Presented at European Society of Cardiology in Munich DUBLIN and MUNICH - August 28, 2018 -Medtronic plc (NYS…
Medtronic Cryoballoon Shows Positive Results for Patients With Persistent Atrial Fibrillation
Diagnostic and Interventional Cardiology,
April 12, 2018 — Medtronic plc announced one-year results from the CRYO4PERSISTENT AF study of ablation with the Arctic Front…
Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation
BioTech Gate,
DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc (NYSE: MDT) today announced one-year results from the…
Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation
Bioportfolio,
DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc (NYSE: MDT) today announced one-year results from the…
News story from Finanz Nachrichten on Monday 19 March 2018
Finanz Nachrichten,
Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation
Benzinga,
DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc (NYSE: MDT) today announced one-year results from the…
Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation
Pettinga: Stock Market,
DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc ( NYSE: MDT ) today announced one-year results from the…
Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation
Wall Street Select : Investor,
DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc ( NYSE: MDT ) today announced one-year results from the…
Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation
Fat Pitch Financials: Stock Quote,
DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc ( NYSE: MDT ) today announced one-year results from the…
News story from The Gazette on Monday 19 March 2018
The Gazette,
Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation
Financial Content,
DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc ( NYSE: MDT ) today announced one-year results from the…
Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation
Minyanville: Finance ,
DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc ( NYSE: MDT ) today announced one-year results from the…
Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation
NASDAQ,
DUBLIN and BARCELONA, Spain - MARCH 19, 2018 -Medtronic plc (NYSE: MDT ) today announced one-year results from the…
Clinical trial to evaluate Medtronic Cryoablation for symptomatic atrial fibrillation
Medicalphysicsweb,
– Medtronic plc (NYSE: MDT) today announced first enrollments in the STOP AF First clinical trial.
Clinical Trial to Evaluate Medtronic Cryoablation as First-Line Treatment for Patients With Symptomatic Paroxysmal Atrial Fibrillation
BioTech Gate,
- Medtronic plc (NYSE: MDT) today announced first enrollments in the STOP AF First clinical trial.
Clinical Trial to Evaluate Medtronic Cryoablation as First-Line Treatment for Patients With Symptomatic Paroxysmal Atrial Fibrillation
Pettinga: Stock Market,
DUBLIN - July 11, 2017 - Medtronic plc ( NYSE: MDT ) today announced first enrollments in the STOP AF First clinical trial.
News story from The Gazette on Tuesday 11 July 2017
The Gazette,
Clinical Trial to Evaluate Medtronic Cryoablation as First-Line Treatment for Patients With Symptomatic Paroxysmal Atrial Fibrillation
Stock Nod: Quotes,
DUBLIN - July 11, 2017 - Medtronic plc ( NYSE: MDT ) today announced first enrollments in the STOP AF First clinical trial.
Clinical Trial to Evaluate Medtronic Cryoablation as First-Line Treatment for Patients With Symptomatic Paroxysmal Atrial Fibrillation
Fat Pitch Financials: Stock Quote,
DUBLIN - July 11, 2017 - Medtronic plc ( NYSE: MDT ) today announced first enrollments in the STOP AF First clinical trial.
Clinical Trial to Evaluate Medtronic Cryoablation as First-Line Treatment for Patients With Symptomatic Paroxysmal Atrial Fibrillation
Wall Street Select : Investor,
DUBLIN - July 11, 2017 - Medtronic plc ( NYSE: MDT ) today announced first enrollments in the STOP AF First clinical trial.
Clinical Trial to Evaluate Medtronic Cryoablation as First-Line Treatment for Patients With Symptomatic Paroxysmal Atrial Fibrillation
Financial Content,
DUBLIN - July 11, 2017 - Medtronic plc ( NYSE: MDT ) today announced first enrollments in the STOP AF First clinical trial.
Clinical Trial to Evaluate Medtronic Cryoablation as First-Line Treatment for Patients With Symptomatic Paroxysmal Atrial Fibrillation
Minyanville: Finance ,
DUBLIN - July 11, 2017 - Medtronic plc ( NYSE: MDT ) today announced first enrollments in the STOP AF First clinical trial.
Clinical Trial to Evaluate Medtronic Cryoablation as First-Line Treatment for Patients With Symptomatic Paroxysmal Atrial Fibrillation
NASDAQ,
-Medtronic plc (NYSE:MDT) today announced first enrollments in the STOP AF First clinical trial.
Clinical Trial To Evaluate Medtronic Cryoablation As First Line Treatment For Patients With Symptomatic Paroxysmal Atrial Fibrillation
Device Space,
DUBLIN - July 11, 2017 - Medtronic plc (NYSE: MDT) today announced first enrollments in the STOP AF First clinical trial.
Clinical Trial To Evaluate Medtronic Cryoablation As First-Line Treatment For Patients With Symptomatic Paroxysmal Atrial Fibrillation
Biospace,
- Medtronic plc (NYSE: MDT) today announced first enrollments in the STOP AF First clinical trial.
Medtronic global trial evaluates cryoablation to treat persistent atrial fibrillation
Medicalphysicsweb,
– Medtronic plc (NYSE: MDT) today announced first enrollments in the STOP Persistent AF clinical trial.
Medtronic Initiates Global Trial Evaluating Cryoablation to Treat Persistent Atrial Fibrillation
BioTech Gate,
- Medtronic plc (NYSE: MDT) today announced first enrollments in the STOP Persistent AF clinical trial.
Medtronic Initiates Global Trial Evaluating Cryoablation to Treat Persistent Atrial Fibrillation
Benzinga,
- Medtronic plc (NYSE: MDT ) today announced first enrollments in the STOP Persistent AF clinical trial.
Medtronic Initiates Global Trial Evaluating Cryoablation to Treat Persistent Atrial Fibrillation
Yahoo! Finance USA,
- Medtronic plc (MDT) today announced first enrollments in the STOP Persistent AF clinical trial.
Medtronic Initiates Global Trial Evaluating Cryoablation to Treat Persistent Atrial Fibrillation
Financial Content,
DUBLIN - March 30, 2017 - Medtronic plc ( NYSE: MDT ) today announced first enrollments in the STOP Persistent AF clinical trial.
Medtronic Initiates Global Trial Evaluating Cryoablation to Treat Persistent Atrial Fibrillation
Fat Pitch Financials: Stock Quote,
DUBLIN - March 30, 2017 - Medtronic plc ( NYSE: MDT ) today announced first enrollments in the STOP Persistent AF clinical trial.
Medtronic Initiates Global Trial Evaluating Cryoablation to Treat Persistent Atrial Fibrillation
Wall Street Select : Investor,
DUBLIN - March 30, 2017 - Medtronic plc ( NYSE: MDT ) today announced first enrollments in the STOP Persistent AF clinical trial.
Medtronic Initiates Global Trial Evaluating Cryoablation to Treat Persistent Atrial Fibrillation
Stock Nod: Quotes,
DUBLIN - March 30, 2017 - Medtronic plc ( NYSE: MDT ) today announced first enrollments in the STOP Persistent AF clinical trial.
Medtronic Initiates Global Trial Evaluating Cryoablation to Treat Persistent Atrial Fibrillation
Pettinga: Stock Market,
DUBLIN - March 30, 2017 - Medtronic plc ( NYSE: MDT ) today announced first enrollments in the STOP Persistent AF clinical trial.
Medtronic Initiates Global Trial Evaluating Cryoablation to Treat Persistent Atrial Fibrillation
Minyanville: Finance ,
DUBLIN - March 30, 2017 - Medtronic plc ( NYSE: MDT ) today announced first enrollments in the STOP Persistent AF clinical trial.
News story from The Gazette on Thursday 30 March 2017
The Gazette,
Medtronic Initiates Global Trial Evaluating Cryoablation to Treat Persistent Atrial Fibrillation
NASDAQ,
-Medtronic plc (NYSE:MDT) today announced first enrollments in the STOP Persistent AF clinical trial.
You Really Can Die of a Broken Heart – Here’s the Science
The Epoch Times,
When you think of a broken heart, you probably picture something out of a romantic movie or a cartoon heart, cracked like a…
You really can die of a broken heart ' science shows us how
Latest Nigerian News,
When you think of a broken heart, you probably picture something out of a romantic movie or a cartoon heart, cracked like a…
You really can die of a broken heart – here's the science
World News SBS,
We can have our hearts broken – and that, for some, this can be very dangerous.
You really can die of a broken heart - science shows us how
Business Insider UK,
See Also For Older Women, Working Out May Keep Heart Rates Regular Falls may be tied to irregular heartbeat Getting in shape…
You really can die of a broken heart — science shows us how
Business Insider,
Apr. 11, 2016, 10:30 PM 1,150 When you think of a broken heart, you probably picture something out of a romantic movie or a…
You really can die of a broken heart – here's the science
The Conversation,
When you think of a broken heart, you probably picture something out of a romantic movie or a cartoon heart, cracked like a…